Non-naturally occurring T cell receptors
AssigneeImmunocore Limited
InventorsBent Karsten Jakobsen, Naomi Harwood, Nathanial Ross Liddy
Life of this patent
Estimating the term…
Abstract
A T cell receptor (TCR) having the property of binding to the gp100 YLEPGPVTA peptide-HLA-A2 complex and comprising a TCR alpha variable domain and/or a TCR beta variable domain, characterized in that the domains are mutated relative to a TCR having the extracellular alpha and beta chain sequences SEQ ID NOs: 2 and that the TCR has a binding affinity for, and/or a binding half-life for, the YLEPGPVTA-HLA-A2 complex at least double that of a reference TCR. Embodiments of the invention such as the use of such TCRs in adoptive therapy, and fusions of such TCRs with therapeutic agents are also described.
Claims34
A non-naturally occurring T cell receptor (TCR) that binds to a YLEPGPVTA (SEQ ID NO:
- 1)-HLA-A2 complex comprising a TCR alpha chain variable domain and a TCR beta chain variable domain, wherein:
- (a) the alpha chain variable domain has
- (i) at least 90% sequence identity to the amino acid sequence comprising amino acids 1 to 109 of SEQ ID NO:
- 2, or
- (ii) at least 90% sequence identity to the amino acids 1 to 109 of SEQ ID NO:
- 2 and has a mutation at one or more positions selected from the group consisting of:
- 94D, 97L, 98V and 102G;
- (b) the beta chain variable domain has
- (i) amino acids 1 to 112 of SEQ ID NO:
- 3, and a mutation at one or more positions selected from the group consisting of:
- 27L, 28N, 29H, 30D, 31A, 50Q, 51I, 52V, 53N, 54D, 61A, 94S, 95I, 96G, 97G, 98P and 100E, or
- (ii) at least 90% sequence identity to the amino acid sequence comprising amino acids 1 to 112 of SEQ ID NO:
- 3;
- (c) the TCR has a binding affinity for, and/or a binding half-life for, the YLEPGPVTA-(SEQ ID NO:
- 1) HLA-A2 complex which is at least double that of a reference TCR, the reference TCR having an extracellular alpha chain sequence of SEQ ID NO:
- 45 and an extracellular beta chain sequence of SEQ ID NO:
- 46;
- and
- (d) at least one of the alpha and beta chain variable domains has at least one mutation.
Dependencies are inferred from the claim text.